MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
31.97
+1.43 (4.68%)
At close: Dec 5, 2025, 4:00 PM EST
31.35
-0.62 (-1.94%)
After-hours: Dec 5, 2025, 7:49 PM EST
MBX Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,436 | 616 | - | - |
| Enterprise Value | 1,044 | 339 | - | - |
| Last Close Price | 31.97 | 18.43 | - | - |
| PB Ratio | 3.69 | 2.39 | - | - |
| P/TBV Ratio | 3.70 | 2.39 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 |
| Quick Ratio | 32.60 | 23.78 | 20.60 | 12.42 |
| Current Ratio | 32.96 | 24.19 | 21.26 | 12.89 |
| Return on Equity (ROE) | -24.43% | -36.71% | -53.75% | - |
| Return on Assets (ROA) | -16.64% | -24.17% | -34.14% | - |
| Return on Capital (ROIC) | -17.22% | -25.23% | -36.20% | - |
| Return on Capital Employed (ROCE) | -23.40% | -26.50% | -44.00% | -60.40% |
| Earnings Yield | -5.61% | -10.05% | - | - |
| FCF Yield | -5.50% | -9.02% | - | - |
| Buyback Yield / Dilution | -1225.35% | -944.70% | -52.73% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.